Retraction: Tocotrienols and its role in cardiovascular health- a lead for drug design (Current Pharmaceutical Design, (2011) 17(21), 10.2174/138161211796957508);Tocotrienols and its role in cardiovascular health- a lead for drug design

Current Pharmaceutical Design

Volumn 17, Issue 21, 2011, Pages 2170-2175

  Vasanthi, Hannah R ^a   Parameswari, R P ^b   Das, Dipak K ^c  

^a PONDICHERRY UNIVERSITY   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Atherosclerosis; Cardiovascular disorders; Cholesterol; Tocotrienols

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; AMILORIDE; CAROTENOID; DEXAMETHASONE; GAMMA TOCOTRIENOL; LACTONE; LOW DENSITY LIPOPROTEIN; PLACEBO; QUERCETIN; RIBOFLAVIN; TOCOPHEROL DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL ADHESION; COGNITIVE DEFECT; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID METABOLISM; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY;

EID: 80052242109     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161282716210430092201     Document Type: Erratum

References (72)

1. Dahlof B. Cardiovascular Disease Risk Factors: Epidemiology and Risk Assessment. Am J Cardiol 2010; 105: 3-9.
2. Borradaile NM, Pickering GJ. NAD, Sirtuins and Cardiovascular Disease. Curr Pharm Des 2009; 15: 110-7.
3. Meng CQ. Inflammation in Atherosclerosis: New Opportunities for Drug Discovery. Mini Rev Med Chem 2005; 5: 33-40.
4. Vasanthi HR, Özer NK, Azzi A, Das DK. Dietary Supplements, Cholesterol and Cardiovascular Disease. F. De Meester et al. (eds.), Modern Dietary Fat Intakes in Disease Promotion. 2010; 227-47.
5. Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med 2002; 251: 372-92.
6. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy- 3-methylglutarylcoenzyme A reductase. J Biol Chem 1993; 268: 11230-8.
7. Guthrie N, Kurowska EM. Anti-cancer and cholesterol-lowering activities of tocotrienols. In: Wildman REC, ed. Handbook of Nutraceuticals and Functional Foods. Boca Raton, FL: CRC Press. 2000: 269-80.
8. Black TM, Wang P, Maeda N, Coleman RA. Palm tocotrienols protect ApoE +/-mice from diet-induced atheroma formation. J Nutr 2000; 130: 2420-6.
9. Newaz MA, Nawal NN. Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). Clin Exper Hypertens 1999; 21: 1297-313.
10. Theriault A, Chao JT, Wang Q, Gapor A, Adeli K. Tocotrienol: a review of its therapeutic potential. Clin Biochem 1999; 32: 309-19.
11. Smogorzewski M. The myopathy of statins. J Ren Nutr 2005; 15: 87-93.
12. Theriault A, Chao JT, Gapor A. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis 2002; 160: 21-30.
13. Qureshi AA, Burger WC, Peterson DM, Elson CE. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 1986; 261: 10544-50.
14. Cicero AF, Gaddi A. Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 2001; 15: 277-89.
15. Qureshi AA, Sami SA, Salser WA, Khan FA. Dosedependent suppression of serum cholesterol by tocotrienolrich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 2002; 161: 199-207.
16. Qureshi AA, Qureshi N, HaslerRapacz JO, et al. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 1991; 53: 1042-6.
17. Qureshi AA, Peterson DM, Hasler-Rapacz JO, Rapacz J. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J Nutr 2001; 131: 223-30.
18. Theriault A, Wang Q, Gapor A, Adeli K. Effects of γ ocotrienol on ApoB Synthesis, Degradation, and Secretion in HepG2 Cells. Arterioscler Thromb Vasc Biol 1999; 19: 704-12.
19. Song BL, Debose-Boyd RA. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase stimulated by δ and γ ocotrienols. J Biol Chem 2006; 281: 25054-61.
20. Mensink RP, Van Houwelingen AC, Kromhout D, Hornstra, G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am. J. Clin. Nutr. 1999; 69: 213-19.
21. Mustad VA, Smith CA, Ruey PP, Edens NK, De Michele SJ. Supplementation with 3 compositionally diVerent tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. Am J Clin Nutr 2002; 76: 1237-43.
22. Quereshi AA, Bradlow BA, Salser WA, Brace LD. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. Nutr Biochem 1997; 8: 290-8.
23. Qureshi AA, Bradlow BA, Brace L, et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 1995; 30, 1171-7.
24. Tan DT, Khor HT, Low WH, Ali A, Gapor A. Effect of a palmoilvitamin E concentrate on the serum and lipoprotein lipids in humans. Am J Clin Nutr 1991; 53: 1027-30.
25. Maximilian BL, McAllister HA. Atherosclerosis: Pathaologic anatomy and pathogenesis. Cardiovascular Medicine 2007, 1581-91.
26. Jialal I, Devaraj S, Venugopal SK. Creactive protein: Risk marker or mediator in atherothrombosis? Hypertension 2004; 44: 1-6.
27. Von der Thusen JH, Kuiper J, Van Berkel TJ, Biessen EA. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 2003; 55: 133-66.
28. Napolitano M, Avanzi L, Manfredini S, Bravo E. Effects of new combinative antioxidant FeAOX-6 and α ocotrienol on macrophage atherogenesis related functions. Vascul Pharmacol 2007; 46: 394-405.
29. Bevilacqua MP, Nelson RM, Mannori G, Oliviero C. Endothelialleukocyte adhesion molecules in human disease. Annu Rev Med 1994; 45: 361-78.
30. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-101.
31. Poston RN, Hascard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaque. Am J Pathol 1992; 77: 2266-71.
32. Sadeghi MM, Collinge M, Pardi R, Bender JR. Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: Involvement of an inhibitory G protein. J Immunol 2000; 165: 2712-8.
33. Liu L, Moesner P, Kovach NL, et al. Integrin-dependent leukocyte adhesion involves geranylgeranylated proteins. J Biol Chem 1999; 274: 33334-40.
34. Laudanna C, Campbell JJ, Butcher EC. Role of Rho in chemo attractant-activated leukocyte adhesion through integrins. Science 1996; 271: 981-3.
35. Naito Y, Shimozawa M, Kuroda M, et al. Tocotrienols reduce 25 hydroxycholesterol-induced monocyte endothelial cell interactions by inhibiting the surface expression of adhesion molecules. Atherosclerosis 2005; 180: 19-25.
36. Qureshi A.A. Reis J.C., Qureshi N. Papasian C.J. Morrison D.C. Schaefer D.M. δ ocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids Health Dis 2011; 10: 39.
37. Qureshi A.A. Reis J.C. Papasian C.J. Morrison D.C. Qureshi N. Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice. Lipids Health Dis 2010; 9: 143.
38. Nafeeza MI, Norzana AG, Jalaluddin HL, Gapor MT. The effects of a tocotrienol-rich fraction on experimentally induced atherosclerosis in the aorta of rabbits. Malays J Pathol 2001; 23: 17-25.
39. Li F, Tan W, Kang Z, Wong CW. Tocotrienol enriched palm oil prevents atherosclerosis through modulating the activities of peroxisome proliferators-activated receptors. Atherosclerosis 2010; 211: 278-82.
40. Wu SJ, Liu PL, Lean-Teik N. γ ocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol Nutr Food Res 2008; 52: 921-9.
41. Yam ML, Abdul Hafid SR, Cheng HM, Nesaretnam K. Tocotrienols Suppress Proinflammatory Markers and Cyclooxygenase- 2 Expression in RAW264.7 Macrophages. Lipids 2009; 44: 787-97.
42. Star RA. Treatment of acute renal failure. Kidney Int 1998; 54: 1817-31.
43. Priya T, Girish T. Ischemic preconditioning of myocardium. Acta Pharmacol Sin 2002; 23: 865-70.
44. Ikeda S, Tohyama T, Yoshimura H, Hamamura K, Abe K, Yamashita K. Dietary α copherol decreases α otrienol but not γ otrienol concentration in rats. J Nutr 2003; 133: 428-34.
45. Serbinova E, Khwaja S, Catudioc J, et al. Palm oil vitamin E protects against ischemia/reperfusion injury in the isolated perfused langendorff heart. Nutr Res Suppl 1992; 12: 203-15.
46. Esterhuyse AJ, du Toit EF, Benade AJS, van Rooyen J. Dietary red palm oil improves reperfusion cardiac function in the isolated perfused rat heart of animals fed a high cholesterol diet. Prostaglandins Leukot Essent Fatty Acids 2005; 72: 153-61.
47. Esterhuyse JS, van Rooyen J, Strijdom H, Bester D, du Toit EF. Proposed mechanisms for red palm oil induced cardioprotection in a model of hyperlipidaemia in the rat. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 375-84.
48. Maulik N, Engelman DT, Watanabe M, et al. Nitric oxide signaling in ischaemic heart. Cardiovasc Res 1995; 30: 593-601.
49. Anna-Mart Engelbrechta T, Esterhuyse J, du Toit EF, Amanda Lochner, van Rooyen J. p38-MAPK and PKB/Akt, possible role players in red palm oil-induced protection of the isolated perfused rat heart? J Nutr Biochem 2006; 17: 265-71.
50. Das M, Das S, Wang P, Powell SR, Das DK. Caveolin and proteasome in tocotrienol mediated myocardial protection. Cell Physiol Biochem 2008: 22: 287-94.
51. Das S, Powell S, Wang P, et al. Cardioprotection with palm tocotrienol: Andioxidant activity of tocotrienol is linked with its ability to stabilize proeasomes. Am J Physiol Heart Circ Physiol 2005; 289: 361-7.
52. Powell SR, Davies KJA, Divald A. Optimal determination of heart tissue 26S Proteasome activity requires maximal stimulating concentrations of ATP. J Mol Cell Cardiol 2007; 42: 265-9.
53. Das S, Lekli I, Das M, et al. Cardioprotection with palm oil tocotrienols: comparision of different isomers. Am J Physiol Heart Circ Physiol 2008; 294: 970-8.
54. Lekli I, Ray D, Mukherjee S, et al. Coordinated autophagy with resveratrol and gamma-tocotrienol confers synergetic cardioprotection. J Cell Mol Med 2009; 14: 2506-18.
55. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-241.
56. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993; 44: 121-31.
57. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
58. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134-46.
59. Assmann G, Cullen P, Jossa F, Lewis B, Mancini M. Coronary heart disease: reducing the risk, the scientific background to primary and secondary prevention of coronary heart disease-a worldwide view. Arterioscler Thromb Vasc Biol 1999; 19: 1819- 24.
60. Garber AJ. The touch that kills. Clin Diab 1995; 13: 57-8.
61. Wan Nazaimoon WM, Khalid BA. Tocotrienols-rich diet decreases advanced glycosylation end-products in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic rats. Malays J Pathol 2002; 24: 77-82.
62. Budin SB, Othman F, Louis SR, Bakar MA, Das S, Mohamed J. The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics (Sao Paulo) 2009; 64: 235-44.
63. Kuhad A, Bishnoi M, Tiwari V, Chopra K. Suppression of NFkappa beta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol Biochem Behav 2009; 92: 251-9.
64. Kuhad A, Chopra K. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology 2009; 57: 456-62.
65. Kuhad A, Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci 2009; 84: 296-301.
66. Fang F, Kang Z, Wong C. Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Mol Nutr Food Res 2010; 54: 345-52.
67. Chou TW, Ma CY, Cheng HH, Chen YY, Lai MH. A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Clin Biochem Nutr 2009; 45: 29-36.
68. Kanaya Y, Doi T, Sasaki H, et al. Rice bran extract prevents the elevation of plasma peroxylipid in KKAy diabetic mice. Diabetes Res Clin Pract 2004; 66: 157-60.
69. Harumi Uto-Kondo, Reiko Ohmori, Chikako Kiyose, et al. Tocotrienol Suppresses Adipocyte Differentiation and Akt Phosphorylation in 3T3-L1 Preadipocytes. J Nutr 2009; 139: 51-7.
70. Newaz MA, Yousefipour Z, Nawal N, Adeeb N. Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: Antioxidant protection by gamma tocotrienol. J Physiol Pharmacol 2003; 54: 319-27.
71. Syed Putra Muharis, Abdul Gapor Md Top, Dharmani Murugan, Mohd Rais Mustafa. Palm oil tocotrienol fractions restore endothelium dependent relaxation in aortic rings of streptozotocin-induced diabetic and spontaneously hypertensive rats. Nutr Res 2010; 30: 209-16.
72. Butler RN. Vitamin E supplements [editorial]. Geriatrics 1997; 52: 7-8.